Glenmark Pharmaceuticals Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
19 Jun 2025HDFC Mutual Fund
Reg29(1)
Acquisition Open Market 357,499
0.13%
— 5.07% No
17 Apr 2023HSBC Global Asset Management (Hong Kong) Limited
Reg29(2)
Sale Open Market — 215,973
0.07%
3.04% No
30 Sep 2020HSBC Global Asset Management (Hong Kong) Limited
Reg29(1)
Acquisition Open Market 204,615
0.07%
— 5.04% No
26 Feb 2018HSBC Global Asset Management (Hong Kong) Limited
Reg29(2)
Acquisition Open Market 143,030
0.05%
— 5.00% No
10 Oct 2017OppenheimerFunds, Inc. (F.I.I)
Reg29(2)
Sale Open Market — 160,000
0.06%
3.01% No
7 Feb 2017OppenheimerFunds, Inc.(F.I.I)
Reg29(2)
Acquisition Open Market 74,647
0.03%
— 5.01% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.